Nagueh S F, Kopelen H A, Zoghbi W A
Department of Medicine, Baylor College of Medicine, and The Methodist Hospital Echocardiography Laboratory, Houston, Texas 77030, USA.
Am Heart J. 1998 Apr;135(4):647-54. doi: 10.1016/s0002-8703(98)70281-9.
Adenosine, a potent coronary vasodilator is used as a pharmacologic stress agent for the assessment of coronary artery disease. A paucity of data exists on its effects on filling dynamics. Accordingly, this study was undertaken to evaluate the effects of adenosine on left ventricular filling as assessed by Doppler echocardiography.
We studied 69 patients (45 men, 24 women, aged 61+/-11 years) referred for evaluation of coronary artery disease. Two-dimensional echocardiography and pulsed-Doppler recordings at the mitral valve tips and annulus were performed at baseline and at maximal adenosine infusion of 140 microg/kg/min. During adenosine infusion, an increase in heart rate occurred (70+/-14 beats/min to 85+/-16 beats/min), with a mild decrease in blood pressure (130/75+/-26/13 mm Hg vs 119/66+/-25/13 mm Hg); both p < 0.02. Changes in filling dynamics included an increase in peak early inflow velocity, E/A ratio, and normalized peak filling rate. Of the patients investigated, 23 had one-vessel coronary artery disease, 29 had coronary disease in two vessels or more by angiography, and 17 had no significant disease. Patients without coronary artery disease (controls) had mild changes in E/A ratio (mean 7%). Patients with coronary artery disease had a more heterogeneous change in filling dynamics (range 43% to 369%, mean 26%), with a significant overlap with controls. However, changes in E/A ratio during adenosine infusion that exceeded the confidence limits of normal (-20% to +30%) were specific for coronary artery disease, with a positive predictive value of 84%.
Normally, adenosine induces significant increases in early filling as assessed by Doppler. The changes in patients with coronary stenosis are more variable. When these changes fall outside the confidence limits of normal, they are predictive of coronary artery disease.
腺苷是一种强效冠状动脉扩张剂,用作评估冠状动脉疾病的药物应激剂。关于其对充盈动力学影响的数据较少。因此,本研究旨在通过多普勒超声心动图评估腺苷对左心室充盈的影响。
我们研究了69例因评估冠状动脉疾病而转诊的患者(45例男性,24例女性,年龄61±11岁)。在基线和最大腺苷输注量为140μg/kg/min时,进行二维超声心动图检查以及二尖瓣叶尖和瓣环处的脉冲多普勒记录。在腺苷输注期间,心率增加(从70±14次/分钟增至85±16次/分钟),血压轻度下降(130/75±26/13mmHg对119/66±25/13mmHg);两者p<0.02。充盈动力学变化包括早期流入峰值速度、E/A比值和标准化峰值充盈率增加。在所研究的患者中,23例有单支冠状动脉疾病,29例通过血管造影显示有两支或更多支冠状动脉疾病,17例无明显疾病。无冠状动脉疾病的患者(对照组)E/A比值变化轻微(平均7%)。患有冠状动脉疾病的患者在充盈动力学方面变化更为多样(范围43%至369%,平均26%),与对照组有明显重叠。然而,腺苷输注期间E/A比值的变化超出正常置信区间(-20%至+30%)对冠状动脉疾病具有特异性,阳性预测值为84%。
正常情况下,腺苷通过多普勒评估可导致早期充盈显著增加。冠状动脉狭窄患者的变化更具变异性。当这些变化超出正常置信区间时,可预测冠状动脉疾病。